Vision Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer with a DRAP-listed facility and activities spanning pharmaceutical finished products and specialized formulation technologies.
Vision Pharmaceuticals products in Pakistan
Vision Pharmaceuticals Pvt Ltd has 86 medicine presentations registered in Pakistan under 41 brands, covering 35 generic medicines. Most of its products are in Anti-infectives, Fluids & supportive care and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Aczon (Ceftriaxone), Medicip (Ciprofloxacin), Visoli (Linezolid) and Colmat (Colistimethate sodium). 86 products have an official DRAP price on MedInfoBase. See all 41 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Vision Pharmaceuticals (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 22-23, Industrial Triangle, Kahuta Road, Islamabad 44000, Pakistan · 44000
- Website
- visionpharmapk.com ↗
- Phone
- +92 321 5171779
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Vision Pharmaceuticals Pvt Ltd is priced against the market
77 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aburid | Ibuprofen | 400 mg/100 mL | IV infusion | 1's | 110894 | PKR 427.13 | PKR 427.13/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 1 g | IV injection | 1’s | 030695 | PKR 619.58 | PKR 619.58/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 250 mg | IV injection | 1’s | 030696 | PKR 196.20 | PKR 196.20/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 500 mg | IV injection | 1’s | 030697 | PKR 351.09 | PKR 351.09/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 250 mg | IM injection | 1’s | 042654 | PKR 208.60 | PKR 208.60/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 500 mg | IM injection | 1’s | 042655 | PKR 351.09 | PKR 351.09/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 1 g | IM injection | 1’s | 042656 | PKR 536.97 | PKR 536.97/vial/unit | 🔒 Pharma Pro |
| Aczon | Ceftriaxone | 2 g | IV injection | 1’s | 094174 | PKR 929.36 | PKR 929.36/vial/unit | 🔒 Pharma Pro |
| Azivis | Azithromycin | 200 mg/5 mL | Suspension | 15ml | 077600 | PKR 345.47 | PKR 23.03/mL | 🔒 Pharma Pro |
| Bakacin | Amikacin | 100 mg | Injection | 1's | 035254 | PKR 84.68 | PKR 84.68/vial/unit | 🔒 Pharma Pro |
| Bakacin | Amikacin | 500 mg/2 mL | Injection | 1's | 035255 | PKR 258.16 | PKR 258.16/vial/unit | 🔒 Pharma Pro |
| Bisovis | Bisoprolol fumarate | 5 mg | Tablet | 20’s | 078167 | PKR 275.85 | PKR 13.79/tablet | 🔒 Pharma Pro |
| ClariocinSource observed | Azithromycin | 125 mg | Dry suspension | 60ml | 078173Official source ↗ | No indexed price | — | — |
| Colmat | Colistimethate sodium | 1 MIU | Dry powder for injection | 1's | 108414 | PKR 2,401.09 | PKR 2,401.09/vial/unit | No comparator |
| Colmat | Colistimethate sodium | 2 MIU | Dry powder for injection | 1's | 119158 | PKR 2,000.07 | PKR 2,000.07/vial/unit | No comparator |
| Colmat | Colistimethate sodium | 3 MIU | Dry powder for injection | 1's | 119159 | PKR 3,000.68 | PKR 3,000.68/vial/unit | No comparator |
| Colmat | Colistimethate sodium | 4.5 MIU (≈150 mg colistin base activity) | Dry powder for injection | 1's | 119160 | PKR 4,501.60 | PKR 4,501.60/vial/unit | No comparator |
| Cortizone | Hydrocortisone | 100 mg | Injection | 1’s | 081898 | PKR 150.76 | PKR 150.76/vial/unit | 🔒 Pharma Pro |
| Cortizone | Hydrocortisone | 250 mg | Injection | 1’s | 081899 | PKR 262.28 | PKR 262.28/vial/unit | 🔒 Pharma Pro |
| Cortizone | Hydrocortisone | 500 mg | Injection | 1’s | 081900 | PKR 590.65 | PKR 590.65/vial/unit | 🔒 Pharma Pro |
| Dexsol | Dextrose | 5 % | IV infusion | 1000ml | 078031 | PKR 169.30 | PKR 0.17/mL | 🔒 Pharma Pro |
| Dexsol | Dextrose Anhydrous | 5% | IV infusion | 500ml | 078037 | PKR 139.84 | PKR 0.28/mL | No comparator |
| Dexsol | Dextrose | 5 % | IV infusion | 100ml | 079566 | PKR 92.01 | PKR 0.92/mL | 🔒 Pharma Pro |
| Dexsol | Dextrose | 10% | IV infusion | 500ml | 104866 | PKR 150.90 | PKR 0.30/mL | 🔒 Pharma Pro |
| Dexsol 1000ml | Dextrose | 10 % | IV infusion | 1000ml | 104865 | PKR 211.62 | PKR 0.21/mL | 🔒 Pharma Pro |
| Dexsol 25% IV | Dextrose | 25 % | IV infusion | 20ml | 079567 | PKR 15.49 | PKR 0.77/mL | 🔒 Pharma Pro |
| Dexsol DS | Dextrose + Sodium chloride | 5% + 0.9% | IV infusion | 1000ml | 078033 | PKR 178.48 | PKR 0.18/mL | 🔒 Pharma Pro |
| Dexsol DS | Dextrose + Sodium chloride | NaCl 0.9% + Dextrose 5%/100 mL | IV infusion | 500ml | 078038 | PKR 149.05 | PKR 0.30/mL | 🔒 Pharma Pro |
| Dexsol DS | Dextrose + Sodium chloride | NaCl 0.45g + Dextrose 5g/100 mL | IV infusion | 500ml | 108328 | PKR 139.85 | PKR 0.28/mL | 🔒 Pharma Pro |
| Diclovis-K 50mg SachetRegistry verified | Diclofenac Potassium | — | — | — | 109783Official source ↗ | No indexed price | — | — |
| Doston | Ondansetron | 4 mg/2 mL | Injection | 1's | 081891 | PKR 872.56 | PKR 872.56/vial/unit | 🔒 Pharma Pro |
| Doston | Ondansetron | 4 mg/4 mL | Injection | 5's | 081891 | PKR 4,362.77 | PKR 872.55/vial/unit | No comparator |
| Doston | Ondansetron | 8 mg/4 mL | Injection | 5's | 081892 | PKR 4,176.95 | PKR 835.39/vial/unit | 🔒 Pharma Pro |
| Duopromol 150mg/500mg TabletRegistry verified | Ibuprofen, Paracetamol | — | — | — | 123515Official source ↗ | No indexed price | — | — |
| Eclaricin | Clarithromycin | 500 mg | Injection | 1’s | 079565 | PKR 165.23 | PKR 165.23/vial/unit | 🔒 Pharma Pro |
| Flexeril | Cefixime | 400 mg | Capsule | 5’s | 030708 | PKR 592.03 | PKR 118.41/capsule | 🔒 Pharma Pro |
| Fotamin IM 250 mg InjectionRegistry verified | Ceftriaxone | — | — | — | 030693Official source ↗ | No indexed price | — | — |
| Fotamin IM 500 mg InjectionRegistry verified | Ceftriaxone | — | — | — | 030694Official source ↗ | No indexed price | — | — |
| Fungiban | Fluconazole | 150 mg | Capsule | 1’s | 077596 | PKR 285.01 | PKR 285.01/capsule | 🔒 Pharma Pro |
| Glarocid | Zoledronic acid | 4 mg/5 mL | Injection | 5ml x 1's | 104864 | PKR 22,510.18 | PKR 4,502.04/mL | No comparator |
| Icozol | Itraconazole | 100 mg | Capsule | 4’S | 078172 | PKR 648.65 | PKR 162.16/capsule | 🔒 Pharma Pro |
| K-SOL IV | Potassium chloride | 74.6 mg | IV infusion | 25ml | 079570 | PKR 16.53 | PKR 0.66/mL | 🔒 Pharma Pro |
| Katafast | Ketamine | 500 mg | Injection | 10ml x 1's | 081888 | PKR 227.18 | PKR 22.72/mL | 🔒 Pharma Pro |
| Kidsol | Dextrose + Sodium chloride | NaCl 0.18% + Dextrose 4.3%/100 mL | IV infusion | 500ml | 078040 | PKR 80.55 | PKR 0.16/mL | 🔒 Pharma Pro |
| Levovis | Levofloxacin | 250 mg | Tablet | 10’s | 032158 | PKR 243.69 | PKR 24.37/tablet | 🔒 Pharma Pro |
| Levovis | Levofloxacin | 500 mg | Tablet | 10’s | 032159 | PKR 487.40 | PKR 48.74/tablet | 🔒 Pharma Pro |
| Lodine | Loratadine | 10 mg | Tablet | 10’s | 041738 | PKR 148.70 | PKR 14.87/tablet | 🔒 Pharma Pro |
| Lumetrin | Artemether | 80 mg/mL | Injection | 5’s | 081890 | PKR 991.34 | PKR 198.27/vial/unit | 🔒 Pharma Pro |
| Macromyd | Azithromycin | 250 mg | Capsule | 6’s | 033769 | PKR 213.56 | PKR 35.59/capsule | 🔒 Pharma Pro |
| Macromyd | Azithromycin | 250 mg | Capsule | 10’s | 033769 | PKR 355.95 | PKR 35.60/capsule | 🔒 Pharma Pro |
All 41 Vision Pharmaceuticals brands in Pakistan
- Aburid Ibuprofen · 400 mg/100 mL infusion
- Aczon Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Azivis Azithromycin · 200 mg/5 mL suspension
- Bakacin Amikacin · 100 mg injection, 500 mg/2 mL injection
- Bisovis Bisoprolol fumarate · 5 mg tablet
- Colmat Colistimethate sodium · 1 MIU injection, 2 MIU injection, 3 MIU injection
- Cortizone Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Dexsol Dextrose, Dextrose Anhydrous · 10% infusion, 5 % infusion, 5% infusion
- Dexsol 1000ml Dextrose · 10 % infusion
- Dexsol 25% IV Dextrose · 25 % infusion
- Dexsol DS Dextrose + Sodium chloride · 5% + 0.9% infusion, NaCl 0.45g + Dextrose 5g/100 mL infusion, NaCl 0.9% + Dextrose 5%/100 mL infusion
- Doston Ondansetron · 4 mg/2 mL injection, 4 mg/4 mL injection, 8 mg/4 mL injection
- Eclaricin Clarithromycin · 500 mg injection
- Flexeril Cefixime · 400 mg capsule
- Fungiban Fluconazole · 150 mg capsule
- Glarocid Zoledronic acid · 4 mg/5 mL injection
- Icozol Itraconazole · 100 mg capsule
- K-SOL IV Potassium chloride · 74.6 mg infusion
- Katafast Ketamine · 500 mg injection
- Kidsol Dextrose + Sodium chloride · NaCl 0.18% + Dextrose 4.3%/100 mL infusion
- Levovis Levofloxacin · 250 mg tablet, 500 mg tablet
- Lodine Loratadine · 10 mg tablet
- Lumetrin Artemether · 80 mg/mL injection
- Macromyd Azithromycin · 250 mg capsule
- Medicip Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/100 mL infusion
- Nestox Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Odimox Moxifloxacin · 400 mg tablet
- Opepzole Omeprazole · 20 mg capsule
- Pcarb 8.4% IV Sodium bicarbonate · 8.4 % infusion
- Rapid Omeprazole · 40 mg injection
- Shine-D Cholecalciferol · 5 mg/mL injection
- Tansomec Tranexamic acid · 1 g/10 mL injection, 500 mg/5 mL injection
- Tazpin Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Thiopental Thiopental · 500 mg injection
- Vanloc Vancomycin · 1 g injection, 500 mg injection
- Visoli Linezolid · 100 mg/5 mL suspension, 200 mg infusion, 400 mg tablet
- Visoline Sodium chloride · 0.9 % infusion
- Visoline IV Sodium chloride · 0.9 % infusion
- Visopen Meropenem · 1000 mg injection, 500 mg injection
- Water Water for Injection · 20 mL injection
- Water for Injection Water for Injection · 10 mL injection, 5 mL injection
Vision Pharmaceuticals: common questions
How many products does Vision Pharmaceuticals have in Pakistan?
Vision Pharmaceuticals Pvt Ltd has 86 registered medicine presentations in Pakistan, sold under 41 brands and covering 35 generic medicines.
What are the main brands of Vision Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Aczon (Ceftriaxone), Medicip (Ciprofloxacin), Visoli (Linezolid), Colmat (Colistimethate sodium) and Dexsol (Dextrose, Dextrose Anhydrous). This is not a sales ranking.
Which therapy areas does Vision Pharmaceuticals cover?
The most products are in Anti-infectives (47), Fluids & supportive care (19), Gastrointestinal & hepatology (5), Dermatology (3) and Anesthesia & critical care (3).
Where can I see Vision Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.